Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-

Aquation of the investigational anticancer drug trans-[Ru(III)Cl4(Hind)2](-) (1, KP1019) results in the formation of mer,trans-[Ru(III)Cl3(Hind)2(H2O)] (2), which was isolated in high yield (85%) and characterized by spectroscopic methods and X-ray crystallography. Dissolution of 2 in acetone, led to its dimerization into [Ru(III)2(mu-Cl)2Cl4(Hind)4] x 2 (Me)2CO (3) in 79% yield, with release of two water molecules. Complex 2 reacts readily with nucleophilic organic molecules, viz., methanol or dimethyl sulfide, at room temperature by replacement of the aqua ligand to give mer,trans-[Ru(III)Cl3(Hind)2(MeOH)] (4) and mer,trans-[Ru(III)Cl3(Hind)2(Me2S)] (5) in 58 and 64% yield, respectively. By reaction of 2 with DMSO at room temperature or dimethyl sulfide at elevated temperatures trans,trans,trans-[Ru(II)Cl2(Hind)2(Me2S)2] (6) and trans,trans,trans-[Ru(II)Cl2(Hind)2(S-DMSO)2] (7) were prepared in 64 and 75% yield, respectively. Dissolution of 2 in acetonitrile or benzonitrile gave rise to mer,trans-[Ru(III)Cl3(Hind)(HNC(Me)ind)] (8a), mer,trans-[Ru(III)Cl3(Hind)(HNC(Ph)ind)] (8b), and trans,trans-[Ru(III)Cl2(HNC(Me)ind)2]Cl (9) in 67, 50, and 23% yield, respectively, upon metal-assisted iminoacylation of indazole, which is unprecedented for ruthenium(III). Furthermore, complex 2 reacts with the DNA-model bases 9-methyladenine (9-meade) and N6,N6-dimethyladenine (6-me2ade) to yield mer,trans-[Ru(III)Cl3(Hind)2(9-meade)] (10) and mer,trans-[Ru(III)Cl3(Hind)2(6-me2ade)] (11) with the purine bases bound to the Ru(III) center via N7 and N3, respectively. Complex 11 represents the first ruthenium complex in which the coordination of the purine ligand N6,N6-dimethyladenine occurs via N3. In addition, the polymer [Na(EtOAc)2Ru(III)(mu-Cl)4(Hind)2]n (12) was crystallized from ethyl acetate/diethyl ether solutions of Na[trans-Ru(III)Cl4(Hind)2] x 1.5 H2O (1a). The reported complexes were characterized by elemental analysis, IR and UV-vis spectroscopy, ESI mass spectrometry, cyclic voltammetry, and X-ray crystallography. Electrochemical investigations give insight into the mechanistic details of the solvolytic behavior of complex 2. The lability of the aqua ligand in 2 suggests that this complex is a potential active species responsible for the high antitumor activity of trans-[Ru(III)Cl4(Hind)2](-).     

Ruthenium complexes with tridentate PNX (X = O, S) donor ligands

The ligands, PhPNXMe (1), PhPNXPh (2), and PhPNSMe (3), (PhPNX = 2-Ph2P-C6H4CH[double bond, length as m-dash]NC6H4X-2; X = O, S) have been prepared. A range of new ruthenium complexes were synthesised using these and related ligands, namely: [{RuCl(PhPNO)}2Cl] (4), [Ru(PhPNO)2] (5), [RuCl(PhPNXR)(PPh3)]BPh4 [X = O, R = Me (6); X = O, R = Ph (7); X = S, R = Me (8)], [{RuCl(PhPNX'R)}2Cl]X [X' = O, R = Me, X = Cl(-) (9); X' = S, R = Me, X = BPh4(-) or PF6(-) (10)], and [RuCl(PhPNO-eta 6C6H5)]BPh4 (11). The catalytic activity of these complexes with respect to the hydrosilyation of acetophenone and the hydrogenation of styrene has been investigated, giving an insight into the requirements for an active complex in these reactions.     

Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole

Reaction of the antitumor complex trans-[Ru(III)Cl4(Hind)2]- (Hind = indazole) with an excess of dimethyl sulfoxide (dmso) in acetone afforded the complex trans,trans,trans-[Ru(II)Cl2(dmso)2(Hind)2] (1). Two other isomeric compounds trans,cis,cis-[Ru(II)Cl2(dmso)2(Hind)2] (2) and cis,cis,cis-[Ru(II)Cl2(dmso)2(Hind)2] (3) have been obtained on refluxing cis-[Ru(II)Cl(2)(dmso)(4)] with 2 equiv. of indazole in ethanol and methanol, respectively. Isomers 1 and 2 react with acetonitrile yielding the complexes trans-[Ru(II)Cl2(dmso)(Hind){HN=C(Me)ind}].CH3CN (4.CH3CN) and trans,cis-[Ru(II)Cl2(dmso)2{HN=C(Me)ind}].H2O (5.H2O), respectively, containing a cyclic amidine ligand resulting from insertion of the acetonitrile C triple bond N group in the N1-H bond of the N2-coordinated indazole ligand in the nomenclature used for 1H-indazole. These are the first examples of the metal-assisted iminoacylation of indazole. The products isolated have been characterized by elemental analysis, IR spectroscopy, UV-vis spectroscopy, electrospray mass-spectrometry, thermogravimetry, differential scanning calorimetry, 1H NMR spectroscopy, and solid-state 13C CP MAS NMR spectroscopy. The isomeric structures of 1-3 and the presence of a chelating amidine ligand in 4 and 5 have been confirmed by X-ray crystallography. The electrochemical behavior of 1-5 and the formation of 5 have been studied by cyclic voltammetry.     

Primary and secondary phosphine complexes of iron porphyrins and ruthenium phthalocyanine: synthesis, structure, and P-H bond functionalization

Reduction of [Fe(III)(Por)Cl] (Por = porphyrinato dianion) with Na2S2O4 followed by reaction with excess PH2Ph, PH2Ad, or PHPh2 afforded [Fe(II)(F20-TPP)(PH2Ph)2] (1a), [Fe(II)(F20-TPP)(PH2Ad)2] (1b), [Fe(II)(F20-TPP)(PHPh2)2] (2a), and [Fe(II)(2,6-Cl2TPP)(PHPh2)2] (2b). Reaction of [Ru(II)(Pc)(DMSO)2] (Pc = phthalocyaninato dianion) with PH2Ph or PHPh2 gave [Ru(II)(Pc)(PH2Ph)2] (3a) and [Ru(II)(Pc)(PHPh2)2] (4). [Ru(II)(Pc)(PH2Ad)2] (3b) and [Ru(II)(Pc)(PH2Bu(t))2] (3c) were isolated by treating a mixture of [Ru(II)(Pc)(DMSO)2] and O=PCl2Ad or PCl2Bu(t) with LiAlH4. Hydrophosphination of CH2=CHR (R = CO2Et, CN) with [Ru(II)(F20-TPP)(PH2Ph)2] or [Ru(II)(F20-TPP)(PHPh2)2] in the presence of (t)BuOK led to the isolation of [Ru(II)(F20-TPP)(P(CH2CH2R)2Ph)2] (R = CO2Et, 5a; CN, 5b) and [Ru(II)(F20-TPP)(P(CH2CH2R)Ph2)2] (R = CO2Et, 6a; CN, 6b). Similar reaction of 3a with CH2=CHCN or MeI gave [Ru(II)(Pc)(P(CH2CH2CN)2Ph)2] (7) or [Ru(II)(Pc)(PMe2Ph)2] (8). The reactions of 4 with CH2=CHR (R = CO2Et, CN, C(O)Me, P(O)(OEt)2, S(O)2Ph), CH2=C(Me)CO2Me, CH(CO2Me)=CHCO2Me, MeI, BnCl, and RBr (R = (n)Bu, CH2=CHCH2, MeC[triple bond]CCH2, HC[triple bond]CCH2) in the presence of (t)BuOK afforded [Ru(II)(Pc)(P(CH2CH2R)Ph2)2] (R = CO2Et, 9a; CN, 9b; C(O)Me, 9c; P(O)(OEt)2, 9d; S(O)2Ph, 9e), [Ru(II)(Pc)(P(CH2CH(Me)CO2Me)Ph2)2] (9f), [Ru(II)(Pc)(P(CH(CO2Me)CH2CO2Me)Ph2)2] (9g), and [Ru(II)(Pc)(PRPh2)2] (R = Me, 10a; Bu(n), 10b; Bn, 10c; CH2CH=CH2, 10d; CH2C[triple bond]CMe, 10e; CH=C=CH2, 10f). X-ray crystal structure determinations revealed Fe-P distances of 2.2597(9) (1a) and 2.309(2) A (2bx 2 CH2Cl2) and Ru-P distances of 2.3707(13) (3b), 2.373(2) (3c), 2.3478(11) (4), and 2.3754(10) A (5b x 2 CH2Cl2). Both the crystal structures of 3b and 4 feature intermolecular C-H...pi interactions, which link the molecules into 3D and 2D networks, respectively.     

Trans ruthenium(II) complexes with NH-bridged tetradentate symmetric and asymmetric polypyridyl ligands

NH-Bridged tetradentate ligands were synthesized to achieve stable trans Ru(II) bis(polypyridyl) complexes. The polypyridyl part of the ligand was either symmetric, as in N,N-bis(1,10-phenanthroline-2-yl)amine (phen-NH-phen), or asymmetric, as in N-(1,10-phenanthroline-2-yl)-N-(6-yl-dipyridyl[2,3-a:2',3'-c]phenazine)amine (dppz-NH-phen). Protonation of phen-NH-phen with trifluoroacetic acid and the subsequent reaction with RuCl3 yield trans-[Ru(phen-NH-phen)Cl2]. The chloro ligands in this compound can easily be replaced by stronger ligands, such as CH3CN and DMSO. In this way, complexes trans-[Ru(phen-NH-phen)(CH3CN)(DMSO)](PF6)2 (1), trans-[Ru(phen-NH-phen)(DMSO)2](PF6)2 (2), and trans-[Ru(phen-NH-phen)(CH3CN)2](PF6)2 (3) were obtained. X-ray structures were determined for 1 and 3. Following a procedure similar to that used with phen-NH-phen, the complex trans-[Ru(dppz-NH-phen)(CH3CN)2](PF6)2 (4) was obtained. To our knowledge, this is the first reported trans ruthenium(II) bis(polypyridyl) complex with two different polypyridyl ligands in the equatorial plane.     

Spectral, structural, and electrochemical properties of ruthenium porphyrin diaryl and aryl(alkoxycarbonyl) carbene complexes: influence of carbene substituents, porphyrin substituents, and trans-axial ligands

A wide variety of ruthenium porphyrin carbene complexes, including [Ru(tpfpp)(CR(1)R(2))] (CR(1)R(2) = C(p-C(6)H(4)Cl)(2) 1 b, C(p-C(6)H(4)Me)(2) 1 c, C(p-C(6)H(4)OMe)(2) 1 d, C(CO(2)Me)(2) 1 e, C(p-C(6)H(4)NO(2))CO(2)Me 1 f, C(p-C(6)H(4)OMe)CO(2)Me 1 g, C(CH==CHPh)CO(2)CH(2)(CH==CH)(2)CH(3) 1 h), [Ru(por)(CPh(2))] (por=tdcpp 2 a, 4-Br-tpp 2 b, 4-Cl-tpp 2 c, 4-F-tpp 2 d, tpp 2 e, ttp 2 f, 4-MeO-tpp 2 g, tmp 2 h, 3,4,5-MeO-tpp 2 i), [Ru(por)[C(Ph)CO(2)Et]] (por=tdcpp 2 j, tmp 2 k), [Ru(tpfpp)(CPh(2))(L)] (L = MeOH 3 a, EtSH 3 b, Et(2)S 3 c, MeIm 3 d, OPPh(3) 3 e, py 3 f), and [Ru(tpfpp)[C(Ph)CO(2)R](MeOH)] (R = CH(2)CH==CH(2) 4 a, Me 4 b, Et 4 c), were prepared from the reactions of [Ru(por)(CO)] with diazo compounds N(2)CR(1)R(2) in dichloromethane and, for 3 and 4, by further treatment with reagents L. A similar reaction of [Os(tpfpp)(CO)] with N(2)CPh(2) in dichloromethane followed by treatment with MeIm gave [Os(tpfpp)(CPh(2))(MeIm)] (3 d-Os). All these complexes were characterized by (1)H NMR, (13)C NMR, and UV/Vis spectroscopy, mass spectrometry, and elemental analyses. X-ray crystal structure determinations of 1 d, 2 a,i, 3 a, b, d, e, 4 a-c, and 3 d-Os revealed Ru==C distances of 1.806(3)-1.876(3) A and an Os==C distance of 1.902(3) A. The structure of 1 d in the solid state features a unique "bridging" carbene ligand, which results in the formation of a one-dimensional coordination polymer. Cyclic voltammograms of 1 a-c, g, 2 a-d, g-k, 3 b-d, 4 a, b, and 3 d-Os show a reversible oxidation couple with E(1/2) values in the range of 0.06-0.65 V (vs Cp(2)Fe(+/0)) that is attributable to a metal-centered oxidation. The influence of carbene substituents, porphyrin substituents, and trans-ligands on the Ru==C bond was examined through comparison of the chemical shifts of the pyrrolic protons in the porphyrin macrocycles ((1)H NMR) and the M==C carbon atoms ((13)C NMR), the potentials of the metal-centered oxidation couples, and the Ru==C distances among the various ruthenium porphyrin carbene complexes. A direct comparison among iron, ruthenium, and osmium porphyrin carbene complexes is made.     

Oxidation of linear trinuclear ruthenium complexes [Ru(3)(dpa)(4)Cl(2)] and [Ru(3)(dpa)(4)(CN)(2)]: synthesis, structures, electrochemical and magnetic properties

The neutral, monocationic, and dicationic linear trinuclear ruthenium compounds [Ru(3)(dpa)(4)(CN)(2)], [Ru(3)(dpa)(4)(CN)(2)][BF(4)], [Ru(3)(dpa)(4)Cl(2)][BF(4)], and [Ru(3)(dpa)(4)Cl(2)][BF(4)](2) (dpa=the anion of dipyridylamine) have been synthesized and characterized by various spectroscopic techniques. Cyclic voltammetric and spectroelectrochemical studies on the neutral and oxidized compounds are reported. These compounds undergo three successive metal-centered one-electron-transfer processes. X-ray structural studies reveal a symmetrical Ru(3) unit for these compounds. While the metal--metal bond lengths change only slightly, the metal--axial ligand lengths exhibit a significant decrease upon oxidation of the neutral complex. The electronic configuration of the Ru(3) unit changes as the axial chloride ligands are replaced by the stronger "pi-acid" cyanide axial ligands. Magnetic measurements and (1)H NMR spectra indicate that [Ru(3)(dpa)(4)Cl(2)] and [Ru(3)(dpa)(4)Cl(2)][BF(4)](2) are in a spin state of S=0 and [Ru(3)(dpa)(4)Cl(2)][BF(4)], [Ru(3)(dpa)(4)(CN)(2)], and [Ru(3)(dpa)(4)(CN)(2)][BF(4)] are in spin states of S=1/2, 1, and 3/2, respectively. These results are consistent with molecular orbital (MO) calculations.     

Synthesis of mononuclear and dinuclear ruthenium(II) tris(heteroleptic) complexes via photosubstitution in bis(carbonyl) precursors

A novel, and quite general, approach for the preparation of tris(heteroleptic) ruthenium(II) complexes is reported. Using this method, which is based on photosubstitution of carbonyl ligands in precursors such as [Ru(bpy)(CO)(2)Cl(2)] and [Ru(bpy)(Me(2)bpy)(CO)(2)](PF(6))(2), mononuclear and dinuclear Ru(II) tris(heteroleptic) polypyridyl complexes containing the bridging ligands 3,5-bis(pyridin-2-yl)-1,2,4-triazole (Hbpt) and 3,5-bis(pyrazin-2-yl)-1,2,4-triazole (Hbpzt) have been prepared. The complexes obtained were purified by column chromatography and characterized by HPLC, mass spectrometry, 1H NMR, absorption and emission spectroscopy and by electrochemical methods. The X-ray structures of the compounds [Ru(bpy)(Me(2)bpy)(bpt)](PF(6))x0.5C(4)H(10)O [1x0.5C(4)H(10)O], [Ru(bpy)(Me(2)bpy)(bpzt)](PF(6))xH(2)O (2xH(2)O) and [Ru(bpy)(Me(2)bpy)(CH(3)CN)(2)](PF(6))(2)xC(4)H(10)O (6xC(4)H(10)O) are reported. The synthesis and characterisation of the dinuclear analogues of 1 and 2, [{Ru(bpy)(Me(2)bpy)}(2)bpt](PF(6))(3)x2H(2)O (3) and [{Ru(bpy)(Me(2)bpy)}(2)bpzt](PF(6))(3) (4), are also described.     

A series of dinuclear homo- and heterometallic complexes with two or three bridging sulfido ligands derived from the tungsten tris(sulfido) complex [Et(4)N][(Me(2)Tp)WS(3)] (Me(2)Tp = hydridotris(3,5-dimethylpyrazol-1-yl)borate)

The generation of heterobimetallic complexes with two or three bridging sulfido ligands from mononuclear tris(sulfido) complex of tungsten [Et(4)N][(Me(2)Tp)WS(3)] (1; Me(2)Tp = hydridotris(3,5-dimethylpyrazol-1-yl)borate) and organometallic precursors is reported. Treatment of 1 with stoichiometric amounts of metal complexes such as [M(PPh(3))(4)] (M = Pt, Pd), [(PtMe(3))(4)(micro(3)-I)(4)], [M(cod)(PPh(3))(2)][PF(6)] (M = Ir, Rh; cod = 1,5-cyclooctadiene), [Rh(cod)(dppe)][PF(6)] (dppe = Ph(2)PCH(2)CH(2)PPh(2)), [CpIr(MeCN)(3)][PF(6)](2) (Cp = eta(5)-C(5)Me(5)), [CpRu(MeCN)(3)][PF(6)], and [M(CO)(3)(MeCN)(3)] (M = Mo, W) in MeCN or MeCN-THF at room temperature afforded either the doubly bridged complexes [Et(4)N][(Me(2)Tp)W(=S)(micro-S)(2)M(PPh(3))] (M = Pt (3), Pd (4)), [(Me(2)Tp)W(=S)(micro-S)(2)M(cod)] (M = Ir, Rh (7)), [(Me(2)Tp)W(=S)(micro-S)(2)Rh(dppe)], [(Me(2)Tp)W(=S)(micro-S)(2)RuCp] (10), and [Et(4)N][(Me(2)Tp)W(=S)(micro-S)(2)W(CO)(3)] (12) or the triply bridged complexes including [(Me(2)Tp)W(micro-S)(3)PtMe(3)] (5), [(Me(2)Tp)W(micro-S)(3)IrCp][PF(6)] (9), and [Et(4)N][(Me(2)Tp)W(micro-S)(3)Mo(CO)(3)] (11), depending on the nature of the incorporated metal fragment. The X-ray analyses have been undertaken to clarify the detailed structures of 3-5, 7, and 9-12.     

Reactivity of dioxoruthenium(VI) porphyrins toward amines. Synthesis and characterization of bis(arylamine)ruthenium(II), bis(arylamido)- and bis(diphenylamido)ruthenium(IV), and oxo(tert-butylimido)ruthenium(VI) porphyrins

Reactions of dioxoruthenium(VI) porphyrins, [Ru(VI)O2(Por)], with p-chloroaniline, trimethylamine, tert-butylamine, p-nitroaniline, and diphenylamine afforded bis(amine)ruthenium(II) porphyrins, [Ru(II)(Por)(L)2] (L-p-ClC6H4NH2, Me3N, Por=TTP, 4-Cl-TPP; L=tBuNH2, Por = TPP, 3,4,5-MeO-TPP, TTP, 4-Cl-TPP, 3,5-Cl-TPP) and bis(amido)ruthenium(IV) porphyrins, [Ru(IV)(Por)(X)2] (X=p-NO2C6H4NH, Por=TTP, 4-Cl-TPP; X = Ph2N, Por = 3,4,5-MeO-TPP, 3,5-Cl-TPP), respectively. Oxidative deprotonation of [Ru(II)(Por)(NH2-p-C6H4Cl)2] in chloroform by air generated bis(arylamido)ruthenium(IV) porphyrins, [RuIV(Por)(NH-p-C6H4Cl)2] (Por=TTP. 4-Cl-TPP). Oxidation of [RuII(Por)-(NH2tBu)2] by bromine in dichloromethane in the presence of tert-butylamine and traces of water produced oxo(imido)ruthenium(VI) porphyrins, [RuVI-O(Por)(NtBu)] (Por=TPP, 3,4,5-MeO-TPP, TTP, 4-Cl-TPP, 3,5-Cl-TPP). These new classes of ruthenium complexes were characterized by 1H NMR, IR, and UV/visible spectroscopy, mass spectrometry, and elemental analysis. The structure of [Ru(IV)(TTP)(NH-p-C6H4Cl)2 . CH2Cl2 was determined by X-ray crystallography. The Ru-N bond length and the Ru-N-C angle of the Ru-NHAr moiety are 1.956(7) A and 135.8(6) degrees, respectively.     

Synthesis, structures, and properties of ruthenium(II) complexes of N-(1,10-phenanthrolin-2-yl)imidazolylidenes

Mononuclear ruthenium complexes [RuCl(L1)(CH(3)CN)(2)](PF(6)) (2a), [RuCl(L2)(CH(3)CN)(2)](PF(6)) (2b), [Ru(L1)(CH(3)CN)(3)](PF(6))(2) (4a), [Ru(L2)(CH(3)CN)(3)](PF(6))(2) (4b), [Ru(L2)(2)](PF(6))(2) (5), [RuCl(L1)(CH(3)CN)(PPh(3))](PF(6)) (6), [RuCl(L1)(CO)(2)](PF(6)) (7), and [RuCl(L1)(CO)(PPh(3))](PF(6)) (8), and a tetranuclear complex [Ru(2)Ag(2)Cl(2)(L1)(2)(CH(3)CN)(6)](PF(6))(4) (3) containing 3-(1,10-phenanthrolin-2-yl)-1-(pyridin-2-ylmethyl)imidazolylidene (L1) and 3-butyl-1-(1,10-phenanthrolin-2-yl)imidazolylidene (L2) have been prepared and fully characterized by NMR, ESI-MS, UV-vis spectroscopy, and X-ray crystallography. Both L1 and L2 act as pincer NNC donors coordinated to ruthenium (II) ion. In 3, the Ru(II) and Ag(I) ions are linked by two bridging Cl(-) through a rhomboid Ag(2)Cl(2) ring with two Ru(II) extending to above and down the plane. Complexes 2-8 show absorption maximum over the 354-428 nm blueshifted compared to Ru(bpy)(3)(2+) due to strong σ-donating and weak π-acceptor properties of NHC ligands. Electrochemical studies show Ru(II)/Ru(III) couples over 0.578-1.274 V.     

Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole

The electrochemical behavior of [trans-RuCl(4)L(DMSO)](-) (A) and [trans-RuCl(4)L(2)](-) (B) [L = imidazole (Him), 1,2,4-triazole (Htrz), and indazole (Hind)] complexes has been studied in DMF, DMSO, and aqueous media by cyclic voltammetry and controlled potential electrolysis. They exhibit one single-electron Ru(III)/Ru(II) reduction involving, at a sufficiently long time scale, metal dechlorination on solvolysis, as well as, in organic media, one single-electron reversible Ru(III)/Ru(IV) oxidation. The redox potential values are interpreted on the basis of the Lever's parametrization method, and particular forms of this linear expression (that relates the redox potential with the ligand E(L) parameter) are proposed, for the first time, for negatively (1-) charged complexes with the Ru(III/II) redox couple center in aqueous phosphate buffer (pH 7) medium and for complexes with the Ru(III/IV) couple in organic media. The E(L) parameter was estimated for indazole showing that this ligand behaves as a weaker net electron donor than imidazole or triazole. The kinetics of the reductively induced stepwise replacement of chloride by DMF were studied by digital simulation of the cyclic voltammograms, and the obtained rate constants were shown to increase with the net electron donor character (decrease of E(L)) of the neutral ligands (DMSO < indazole < triazole < imidazole) and with the basicity of the ligated azole, factors that destabilize the Ru(II) relative to the Ru(III) form of the complexes. The synthesis and characterization of some novel complexes of the A and B series are also reported, including the X-ray structural analyses of (Ph(3)PCH(2)Ph)[trans-RuCl(4)(Htrz)(DMSO)], [(Ph(3)P)(2)N][trans-RuCl(4)(Htrz)(DMSO)], (H(2)ind)[trans-RuCl(4)(Hind)(DMSO)], and [(Hind)(2)H][trans-RuCl(4)(Hind)(2)].     

Kinetic and mechanistic study of the Pt(II) versus Pt(IV) effect in the platinum-mediated nitrile-hydroxylamine coupling

The metal-mediated coupling between coordinated EtCN in the platinum(II) and platinum(IV) complexes cis- and trans-[PtCl(2)(EtCN)(2)], trans-[PtCl(4)(EtCN)(2)], a mixture of cis/trans-[PtCl(4)(EtCN)(2)] or [Ph(3)PCH(2)Ph][PtCl(n)(EtCN)] (n = 3, 5), and dialkyl- and dibenzylhydroxylamines R(2)NOH (R = Me, Et, CH(2)Ph, CH(2)C(6)H(4)Cl-p) proceeds smoothly in CH(2)Cl(2) at 20-25 degrees C and the subsequent workup allowed the isolation of new imino species [PtCl(n){NH=C(Et)ONR(2)}(2)] (n = 2, R = Me, cis-1 and trans-1; Et, cis-2 and trans-2; CH(2)Ph, cis-3 and trans-3; CH(2)C(6)H(4)Cl-p, cis-4 and trans-4; n = 4, R = Me, trans-9; Et, trans-10; CH(2)Ph, trans-11; CH(2)C(6)H(4)Cl-p, trans-12) or [Ph(3)PCH(2)Ph][PtCl(n){NH=C(Et)ONR(2)}] (n = 3, R = Me, 5; Et, 6; CH(2)Ph, 7; CH(2)C(6)H(4)Cl-p, 8; n = 5, R = Me, 13; Et, 14; CH(2)Ph, 15; CH(2)C(6)H(4)Cl-p, 16) in excellent to good (95-80%) isolated yields. The reduction of the Pt(IV) complexes 9-16 with the ylide Ph(3)P=CHCO(2)Me allows the synthesis of Pt(II) species 1-8. The compounds 1-16 were characterized by elemental analyses (C, H, N), FAB-MS, IR, (1)H, (13)C{(1)H}, and (31)P{(1)H} NMR (the latter for the anionic type complexes 5-8 and 13-16) and by X-ray crystallography for the Pt(II) (cis-1, cis-2, and trans-4) and Pt(IV) (15) species. Kinetic studies of addition of R(2)NOH (R = CH(2)C(6)H(4)Cl-p) to complexes [Ph(3)PCH(2)Ph][Pt(II)Cl(3)(EtCN)] and [Ph(3)PCH(2)Ph][Pt(IV)Cl(5)(EtCN)] by the (1)H NMR technique revealed that both reactions are first order in (p-ClC(6)H(4)CH(2))(2)NOH and Pt(II) or Pt(IV) complex, the second-order rate constant k(2) being three orders of magnitude larger for the Pt(IV) complex. The reactions are intermolecular in nature as proved by the independence of k(2) on the concentrations of added EtC triple bond N and Cl(-). These data and the calculated values of Delta H++ and Delta S++ are consistent with the mechanism involving the rate-limiting nucleophilic attack of the oxygen of (p-ClC(6)H(4)CH(2))(2)NOH at the sp-carbon of the C triple bond N bond followed by a fast proton migration.     

Reactivity and spectroscopy of the {Ru(DMAP)5} fragment: an {Ru(NH3)5} analogue

Reaction of trans-Ru(DMSO)4Cl2 with DMAP (DMAP = 4-dimethylaminopyridine) yields the yellow [Ru(DMAP)6](2+) cation in good yield. The crystal and molecular structure of [Ru(DMAP)6]Cl2.6CH3CH2OH was determined by X-ray diffraction methods. The complex crystallizes in the trigonal R3 space group with a = b = 16.373(1), c = 20.311(1) A, gamma = 120 degrees , and Z = 3 molecules per unit cell. The reaction of [Ru(DMAP)6](2+) in aerobic water gives the red [Ru(III)(DMAP)5(OH)](2+) cation. This complex shows a chemical behavior similar to [Ru(III)(NH3)5Cl](2+) and allows the preparation of a family of [Ru(DMAP)5L](n+) complexes. Their electronic properties indicate that the {Ru(II)(DMAP)5} fragment is a weaker pi-donor than {Ru(II)(NH 3)5}. Our density functional theory (DFT) calculations show that in {Ru(II)(DMAP)5} the DMAP ligands can compete for the pi electron density of the ruthenium making the fragment a weaker pi-donor.     

Ruthenium(II) polypyridyl complexes: potential precursors, metalloligands, and topo II inhibitors

Neutral and cationic mononuclear complexes containing both group 15 and polypyridyl ligands [Ru(kappa3-tptz)(PPh3)Cl2] [1; tptz=2,4,6-tris(2-pyridyl)-1,3,5-triazine], [Ru(kappa3-tptz)(kappa2-dppm)Cl]BF4 [2; dppm=bis(diphenylphosphino)methane], [Ru(kappa3-tptz)(PPh3)(pa)]Cl (3; pa=phenylalanine), [Ru(kappa3-tptz)(PPh3)(dtc)]Cl (4; dtc=diethyldithiocarbamate), [Ru(kappa3-tptz)(PPh3)(SCN)2] (5) and [Ru(kappa3-tptz)(PPh3)(N3)2] (6) have been synthesized. Complex 1 has been used as a metalloligand in the synthesis of homo- and heterodinuclear complexes [Cl2(PPh3)Ru(micro-tptz)Ru(eta6-C6H6)Cl]BF4 (7), [Cl2(PPh3)Ru(mu-tptz)Ru(eta6-C10H14)Cl]PF6 (8), and [Cl2(PPh3)Ru(micro-tptz)Rh(eta5-C5Me5)Cl]BF4 (9). Complexes 7-9 present examples of homo- and heterodinuclear complexes in which a typical organometallic moiety [(eta6-C6H6)RuCl]+, [(eta6-C10H14)RuCl]+, or [(eta5-C5Me5)RhCl]+ is bonded to a ruthenium(II) polypyridine moiety. The complexes have been fully characterized by elemental analyses, fast-atom-bombardment mass spectroscopy, NMR (1H and 31P), and electronic spectral studies. Molecular structures of 1-3, 8, and 9 have been determined by single-crystal X-ray diffraction analyses. Complex 1 functions as a good precursor in the synthesis of other ruthenium(II) complexes and as a metalloligand. All of the complexes under study exhibit inhibitory effects on the Topoisomerase II-DNA activity of filarial parasite Setaria cervi and beta-hematin/hemozoin formation in the presence of Plasmodium yoelii lysate.     

Cubane-type Fe4S4 clusters with chiral thiolate ligation: formation by ligand substitution, detection of intermediates by 1H NMR, and solid state structures including spontaneous resolution upon crystallization

Cubane-type clusters [Fe(4)S(4)(SR*)(4)](2-) containing chiral thiolate ligands with R* = CH(Me)Ph (1), CH(2)CH(Me)Et (2), and CH(2)CH(OH)CH(2)OH (3) have been prepared by ligand substitution in the reaction systems [Fe(4)S(4)(SEt)(4)]/R*SH (1-3, acetonitrile) and [Fe(4)S(4)Cl(4)](2-)/NaSR*(3, Me(2)SO). Reactions with successive equivalents of thiol or thiolate generate the species [Fe(4)S(4)L(4-n)(SR*)(n)](2-) (L = SEt, Cl) with n = 1-4. Clusters 1 and 2 were prepared with racemic thiols leading to the possible formation of one enantiomeric pair (n = 1) and seven diastereomers and their enantiomers (n = 2-4). Reactions were monitored by isotropically shifted (1)H NMR spectra in acetonitrile or Me(2)SO. In systems affording 1 and 2 as final products, individual mixed-ligand species could not be detected. However, crystallization of (Et(4)N)(2)[1] afforded 1-[SS(RS)(RS)] in which two sites are disordered because of occupancy of R and S ligands. Similarly, (Et(4)N)(2)[2] led to 2-[SSSS], a consequence of spontaneous resolution upon crystallization. The clusters 3-[RRRR] and 3-[SSSS] were obtained from enantiomerically pure thiols. Successive reactions lead to detection of species with n = 1-4 by appearance of four pairs of diastereotopic SCH(2) signals in both acetonitrile and Me(2)SO reaction systems. Identical spectra were obtained with racemic, R-(-), and S-(+) thiols, indicating that ligand-ligand interactions are too weak to allow detection of diastereomers (e.g., [SSSS] vs [SSRR]). The stability of 3 in Me(2)SO/H(2)O media is described.     

En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2

By controlled Anderson type rearrangement reactions complexes of the general formula trans-[Os(IV)Cl(4)(Hazole)(2)], where Hazole = 1H-pyrazole, 2H-indazole, 1H-imidazole, and 1H-benzimidazole, have been synthesized. Note that 2H-indazole tautomer stabilization in trans-[Os(IV)Cl(4)(2H-indazole)(2)] is unprecedented in coordination chemistry of indazole. The metal ion in these compounds possesses the same coordination environment as ruthenium(III) in (H(2)ind)[Ru(III)Cl(4)(Hind)(2)], where Hind = 1H-indazole, (KP1019), an investigational anticancer drug in phase I clinical trials. These osmium(IV) complexes are appropriate precursors for the synthesis of osmium(III) analogues of KP1019. In addition the formation of an adduct of trans-[Os(IV)Cl(4)(Hpz)(2)] with cucurbit[7]uril is described. The compounds have been comprehensively characterized by elemental analysis, EI and ESI mass spectrometry, spectroscopy (IR, UV-vis, 1D and 2D NMR), cyclic voltammetry, and X-ray crystallography. Their antiproliferative acitivity in the human cancer cell lines CH1 (ovarian carcinoma), A549 (nonsmall cell lung carcinoma), and SW480 (colon carcinoma) is reported.     

Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes

Arene ruthenium(II) complexes containing bis(pyrazolyl)methane ligands have been prepared by reacting the ligands L' (L' in general; specifically L(1) = H(2)C(pz)(2), L(2) = H(2)C(pz(Me2))(2), L(3) = H(2)C(pz(4Me))(2), L(4) = Me(2)C(pz)(2) and L(5) = Et(2)C(pz)(2) where pz = pyrazole) with [(arene)RuCl(mu-Cl)](2) dimers (arene = p-cymene or benzene). When the reaction was carried out in methanol solution, complexes of the type [(arene)Ru(L')Cl]Cl were obtained. When L(1), L(2), L(3), and L(5) ligands reacted with excess [(arene)RuCl(mu-Cl)](2), [(arene)Ru(L')Cl][(arene)RuCl(3)] species have been obtained, whereas by using the L(4) ligand under the same reaction conditions the unexpected [(p-cymene)Ru(pzH)(2)Cl]Cl complex was recovered. The reaction of 1 equiv of [(p-cymene)Ru(L')Cl]Cl and of [(p-cymene)Ru(pzH)(2)Cl]Cl with 1 equiv of AgX (X = O(3)SCF(3) or BF(4)) in methanol afforded the complexes [(p-cymene)Ru(L')Cl](O(3)SCF(3)) (L' = L(1) or L(2)) and [(p-cymene)Ru(pzH)(2)Cl]BF(4), respectively. [(p-cymene)Ru(L(1))(H(2)O)][PF(6)](2) formed when [(p-cymene)Ru(L(1))Cl]Cl reacts with an excess of AgPF(6). The solid-state structures of the three complexes, [(p-cymene)Ru{H(2)C(pz)(2)}Cl]Cl, [(p-cymene)Ru{H(2)Cpz(4Me))(2)}Cl]Cl, and [(p-cymene)Ru{H(2)C(pz)(2)}Cl](O(3)SCF(3)), were determined by X-ray crystallographic studies. The interionic structure of [(p-cymene)Ru(L(1))Cl](O(3)SCF(3)) and [(p-cymene)Ru(L')Cl][(p-cymene)RuCl(3)] (L' = L(1) or L(2)) was investigated through an integrated experimental approach based on NOE and pulsed field gradient spin-echo (PGSE) NMR experiments in CD(2)Cl(2) as a function of the concentration. PGSE NMR measurements indicate the predominance of ion pairs in solution. NOE measurements suggest that (O(3)SCF(3))(-) approaches the cation orienting itself toward the CH(2) moiety of the L(1) (H(2)C(pz)(2)) ligand as found in the solid state. Selected Ru species have been preliminarily investigated as catalysts toward styrene oxidation by dihydrogen peroxide, [(p-cymene)Ru(L(1))(H(2)O)][PF(6)](2) being the most active species.     

Chromium(III) stars and butterflies: synthesis, structural and magnetic studies of tetrametallic clusters

We report the synthesis, structures and magnetic properties of a series of chromium(III) metal-centered triangle (or "star") clusters, [Cr(4){RC(CH(2)O)(3)}(2)(4,4'-R'(2)-bipy)(3)Cl(6)] [R = Et, R' = H (2); R = HOCH(2), R' = H (3); R = Et, R' = (t)Bu (4)], prepared by two-step solvothermal reactions starting from [CrCl(3)(thf)(3)]. The product of the first stage of this reaction is the salt [Cr(bipy)(2)Cl(2)](2)[Cr(2)Cl(8)(MeCN)(2)] (1). In the absence of the diimine, a different family of tetrametallics is isolated: the butterfly complexes [Cr(4){EtC(CH(2)O)(3)}(2){NH(C(R)NH)(2)}(2)Cl(6)] (R = Me (5), Et (6), Ph (7)] where the chelating N-acetimidoylacetamidine NH(C(R)=NH)(2) ligands are formed in situ via condensation of the nitrile solvents (RCN) under solvothermal conditions. Magnetic measurements show the chromium stars to have an isolated S = 3 ground state, arising from antiferromagnetic coupling between the central and peripheral metal ions, analogous to the well-known Fe(III) stars. Bulk antiferromagnetic ordering is observed at 0.6 K. The butterfly complexes have a singlet ground state, with a low-lying S = 1 first excited state, due to dominant wing-body antiferromagnetic coupling.     

Complexes of germanium(IV) fluoride with phosphane ligands: structural and spectroscopic authentication of germanium(IV) phosphane complexes

The first phosphane complexes of germanium(iv) fluoride, trans-[GeF(4)(PR(3))(2)] (R = Me or Ph) and cis-[GeF(4)(diphosphane)] (diphosphane = R(2)P(CH(2))(2)PR(2), R = Me, Et, Ph or Cy; o-C(6)H(4)(PR(2))(2), R = Me or Ph) have been prepared from [GeF(4)(MeCN)(2)] and the ligands in dry CH(2)Cl(2) and characterised by microanalysis, IR, Raman, (1)H, (19)F{(1)H} and (31)P{(1)H} NMR spectroscopy. The crystal structures of [GeF(4)(diphosphane)] (diphosphane = Ph(2)P(CH(2))(2)PPh(2) and o-C(6)H(4)(PMe(2))(2)) have been determined and show the expected cis octahedral geometries. In anhydrous CH(2)Cl(2) solution the complexes are slowly converted into the corresponding phosphane oxide adducts by dry O(2). The apparently contradictory literature on the reaction of GeCl(4) with phosphanes is clarified. The complexes trans-[GeCl(4)(AsR(3))(2)] (R = Me or Et) are obtained from GeCl(4) and AsR(3) either without solvent or in CH(2)Cl(2), and the structures of trans-[GeCl(4)(AsEt(3))(2)] and Et(3)AsCl(2) determined. Unexpectedly, the complexes of GeF(4) with arsane ligands are very unstable and have not been isolated in a pure state. The behaviour of the germanium(iv) halides towards phosphane and arsane ligands are compared with the corresponding silicon(iv) and tin(iv) systems.